- Home
- HIPO vs BCYC Comparison
HIPO vs BCYC Comparison
Compare HIPO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIPO
- BCYC
- Stock Information
- Founded
- HIPO 2015
- BCYC 2009
- Country
- HIPO United States
- BCYC United Kingdom
- Employees
- HIPO N/A
- BCYC N/A
- Industry
- HIPO Property-Casualty Insurers
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- HIPO Finance
- BCYC Health Care
- Exchange
- HIPO Nasdaq
- BCYC Nasdaq
- Market Cap
- HIPO N/A
- BCYC 581.7M
- IPO Year
- HIPO N/A
- BCYC 2019
- Fundamental
- Price
- HIPO $20.57
- BCYC $8.18
- Analyst Decision
- HIPO Buy
- BCYC Buy
- Analyst Count
- HIPO 3
- BCYC 10
- Target Price
- HIPO $30.33
- BCYC $25.00
- AVG Volume (30 Days)
- HIPO 164.0K
- BCYC 370.6K
- Earning Date
- HIPO 05-07-2025
- BCYC 05-01-2025
- Dividend Yield
- HIPO N/A
- BCYC N/A
- EPS Growth
- HIPO N/A
- BCYC N/A
- EPS
- HIPO N/A
- BCYC N/A
- Revenue
- HIPO $397,300,000.00
- BCYC $25,722,000.00
- Revenue This Year
- HIPO $26.97
- BCYC N/A
- Revenue Next Year
- HIPO $20.14
- BCYC $0.27
- P/E Ratio
- HIPO N/A
- BCYC N/A
- Revenue Growth
- HIPO 55.80
- BCYC N/A
- 52 Week Low
- HIPO $14.58
- BCYC $6.10
- 52 Week High
- HIPO $35.44
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- HIPO 32.07
- BCYC 48.36
- Support Level
- HIPO $23.48
- BCYC $7.95
- Resistance Level
- HIPO $24.65
- BCYC $9.55
- Average True Range (ATR)
- HIPO 0.85
- BCYC 0.73
- MACD
- HIPO -0.06
- BCYC 0.05
- Stochastic Oscillator
- HIPO 6.93
- BCYC 38.84
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.